These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 12653029)
1. [Compliance to treatment and type 2 diabetes: impact on glycemic balance]. Guillausseau PJ Presse Med; 2003 Jan; 32(2):70. PubMed ID: 12653029 [No Abstract] [Full Text] [Related]
2. [Start of insulin therapy. How to ensure patient compliance?]. MMW Fortschr Med; 2006 Aug; 148(35-36):12-3. PubMed ID: 16995354 [No Abstract] [Full Text] [Related]
3. Moving beyond HbA1c and plasma glucose levels to understand glycemic status in type 2 diabetes mellitus. Vijayakumar V; Mavathur R; Aruchunan M; Nandi Krishnamurthy M J Diabetes; 2018 Jul; 10(7):609-610. PubMed ID: 29437298 [No Abstract] [Full Text] [Related]
4. [Compliance and optimisation of oral antidiabetic therapy. A longitudinal study]. Guillausseau PJ Presse Med; 2004 Feb; 33(3):156-60. PubMed ID: 15029026 [TBL] [Abstract][Full Text] [Related]
5. Case study 2: new insights: clinical pearls for using incretin mimetics in type 2 diabetes. Peters AL; Miller D Diabetes Educ; 2007; 33 Suppl 1():14S-19S. PubMed ID: 17272804 [No Abstract] [Full Text] [Related]
6. [American Diabetes Association's Annual Meeting: new data on insulin glargine: early combination promises more success]. MMW Fortschr Med; 2005 Aug; 147(33-34):44-5. PubMed ID: 16138636 [No Abstract] [Full Text] [Related]
7. [Self monitoring of blood glucose: tool for successful diabetes therapy]. Hummel M MMW Fortschr Med; 2012 Nov; 154(20):65-8. PubMed ID: 23234124 [No Abstract] [Full Text] [Related]
8. [New fast-acting insulin analog. This insulin profits type l and type 2 diabetics]. Wepner U MMW Fortschr Med; 2004 Nov; 146(47):62-3. PubMed ID: 15624662 [No Abstract] [Full Text] [Related]
9. [Certain beginning of insulin therapy: yes, we can, but...]. Rohrer A Praxis (Bern 1994); 2009 Mar; 98(6):301. PubMed ID: 19338117 [No Abstract] [Full Text] [Related]
12. Treatment of glycemic control in diabetes in the CVOT era. Einhorn D J Diabetes; 2020 Jan; 12(1):4. PubMed ID: 31746129 [No Abstract] [Full Text] [Related]
14. Comments on the AACE/ACE statement on glycemic control for patients with type 2 diabetes mellitus. Eledrisi M Endocr Pract; 2010; 16(1):130-1; author reply 131-2. PubMed ID: 20146995 [No Abstract] [Full Text] [Related]
15. Comparison of glycemic control of type 2 diabetes between private hospital and governmental hospital. Al-Shaikh AA Saudi Med J; 2006 Mar; 27(3):424-6. PubMed ID: 16532119 [No Abstract] [Full Text] [Related]
16. [Supplemental insulin therapy of type 2 diabetes follows the example of nature. Replace what the patient lacks]. MMW Fortschr Med; 2004 May; 146(22):47. PubMed ID: 15373112 [No Abstract] [Full Text] [Related]
17. Refill adherence to oral hypoglycemic agents and glycemic control in veterans. Kim N; Agostini JV; Justice AC Ann Pharmacother; 2010 May; 44(5):800-8. PubMed ID: 20388863 [TBL] [Abstract][Full Text] [Related]
18. Glycemic control in patients with type 2 diabetes mellitus switched from twice-daily immediate-release metformin to a once-daily extended-release formulation. Fujioka K; Pans M; Joyal S Clin Ther; 2003 Feb; 25(2):515-29. PubMed ID: 12749511 [TBL] [Abstract][Full Text] [Related]
19. Glycemic variability: too often overlooked in type 2 diabetes? Johnson EL J Fam Pract; 2010 Aug; 59(8):E1-8. PubMed ID: 20714447 [TBL] [Abstract][Full Text] [Related]
20. Assessment of community-managed blood glucose control in patients with diabetes mellitus in Shenzhen, China. Fang L; Li Q; Ning J J Diabetes; 2024 Jul; 16(7):e13573. PubMed ID: 38923123 [No Abstract] [Full Text] [Related] [Next] [New Search]